Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | IGSF8 |
| Gene Name: | IGSF8 |
| Protein Full Name: | Immunoglobulin superfamily member 8 |
| Alias: | CD81 partner 3;Glu-Trp-Ile EWI motif-containing protein 2;Keratinocytes-associated transmembrane protein 4;LIR-D1 |
| Mass (Da): | 65034 |
| Number AA: | 613 |
| UniProt ID: | Q969P0 |
| Locus ID: | 93185 |
| COSMIC ID: | IGSF8 |
| Gene location on chromosome: | 1q23.1 |
| Cancer protein type: | TSP |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | INHIBITS |
| Number of cancer specimens: | 19626 |
| Percent of cancer specimens with mutations: | 0.49 |
| Normal role description: | Interacts with tetraspanins CD9, CD81, and CD82 and integrins alpha-3/beta-1 and alpha-4/beta-1. Suggested to play a key role in oocytes fertilization and hepatitis C virus infection. Inhibits cell movement and aggregation, negatively regulates proliferation. |
| Commentary on involvement of protein in cancer: | No mutations have been reported on the Atlas of Genetics in Oncology or the SANGER COSMIC database. |